VCA Stocks

AGI Dermatics, the biopharmaceutical company focused on the development and sale of skincare products utilizing DNA repair technology, announced today it closed a $5 million investment round.  AGI Dermatics is the biopharmaceutical company that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system and its proprietary brand, Remergent®. Advancing the link between science and beauty, the company’s application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in dozens of peer-reviewed scientific and medical journals.